BofA lowered the firm’s price target on Novavax (NVAX) to $12 from $14 and keeps a Neutral rating on the shares. The company announced ...

J.P. Morgan analyst Eric Joseph maintained a Sell rating on Novavax (NVAX – Research Report) yesterday and set a price target of $9.00. Eric Joseph has given his Sell rating due to a combination of ...

(Reuters) -Novavax cut its annual revenue forecast on Tuesday, citing lower-than-expected sales of its COVID-19 vaccine, ...

Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced ...

Health officials say it's important to get flu and COVID-19 vaccines ahead of the holidays when respiratory bugs tend to ...

(Reuters) - U.S. stock index futures dipped on Tuesday after Wall Street's rally over the past few days following election ...

A clinical trial has found that Novavax’ COVID-19 vaccine is 86% protective against the UK variant of SARS-CoV-2, only slightly lower than the 96% efficacy seen with the original strain of the ...

On November 1, Novavax, Inc. (NASDAQ:NVAX) and the U.K. Health Security Agency, representing the U.K. Secretary of State for Health and Social Care, signed a Termination and Settlement Agreement ...

Inovio Pharmaceuticals Inc.-3.56% $138.65M ...

A trial participant developed amytrophic lateral sclerosis (ALS), an event deemed unrelated to vaccination. Novavax’s shares jumped in pre-market trading on the news but settled once markets opened.

On September 15, 1980, American rocker Pat Benatar released her single Hit Me With Your Best Shot. Eddie Schwartz, who wrote and produced the song, was inspired after he started using bioenergetics.